Success of long-lasting HIV drug hinges on pricing
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drug
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
HIV treatment breakthroughs: Namibia's success story
Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for people like Anna Engomba, the arrival of new, life-saving medication cannot ...
BlackDoctor15h
Essential Tips When Caring For An HIV-Positive Child
Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Medscape6d
HIV-Positive Donors Safe for Kidney Transplants
The availability of such kidney transplants outside of the research setting could substantially improve organ availability ...
pharmaphorum3d
Gilead, MSD say HIV combo could be weekly, oral HIV drug
Those include Sunlenca, which is approved for resistant HIV as a twice-yearly injection after an initial oral regimen, and ...
El País in English1d
HIV infection in six transplant patients in Brazil points to nepotism and greed of a laboratory
Health authorities in Rio de Janeiro are reviewing samples from 288 donors after discovering that two HIV-positive people ...
GlobalData on MSN1d
Gilead and MSD to advance once-weekly HIV treatment to Phase III
The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Times West Virginian5dOpinion
Biden-Harris admin must act to ensure equitable access to HIV prevention drugs
The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...
Graphic1d
Funding inadequacy setback for HIV elimination — AIDS Commission
The Ghana AIDS Commission (GAC) says the lack of funding can  impact negatively efforts to end AIDS as a public health threat ...
HIV cases rising in Alberta, sparking need for broad outreach, experts say
Doctors and front-line workers are watching closely as HIV rates increase significantly in Alberta.An annual Alberta Health ...
Zacks.com on MSN2d
Gilead, MRK Report Data From Investigational Combination Study for HIV
Gilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...